Search

Your search keyword '"Thorens Bernard"' showing total 971 results

Search Constraints

Start Over You searched for: Author "Thorens Bernard" Remove constraint Author: "Thorens Bernard"
971 results on '"Thorens Bernard"'

Search Results

2. GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion

8. The glucose transporter 2 regulates CD8+ T cell function via environment sensing

10. Identification of biomarkers for glycaemic deterioration in type 2 diabetes

13. Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes

15. Neuronal glucose sensing mechanisms and circuits in the control of insulin and glucagon secretion.

19. SAT-231 GL0034 (Utreglutide), a long acting, glucagon-like peptide-1 receptor agonist, improves body weight loss, lipid and liver injury markers in individuals with obesity: A phase 1 multiple ascending dose study

23. Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study

24. Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes

26. Building the Glucagon-Like Peptide-1 Receptor Brick by Brick: Revisiting a 1993 Diabetes Classic by Thorens et al.

30. Laser capture microdissection of human pancreatic islets reveals novel eQTLs associated with type 2 diabetes

32. GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion

34. Hyperglycemia increases SCO-spondin and Wnt5a secretion into the cerebrospinal fluid to regulate ependymal cell beating and glucose sensing

36. Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion

37. Hypothalamic CDK4 regulates thermogenesis by modulating sympathetic innervation of adipose tissues

39. Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes

40. Fostering improved human islet research: a European perspective

43. Protective role of the ELOVL2/docosahexaenoic acid axis in glucolipotoxicity-induced apoptosis in rodent beta cells and human islets

44. GL0034 (Utreglutide), a novel, long acting, glucagon-like peptide 1 receptor agonist (GLP-1 RA), results of a phase 1 study in healthy individuals

45. Gene expression signature predicts rate of type 1 diabetes progression

46. Glucagon receptor family in GtoPdb v.2023.1

49. Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App:Survey and Interview Study

Catalog

Books, media, physical & digital resources